Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans.

Bouhnik, Y; Vahedi, K; Achour, L; Attar, A; Salfati, J; Pochart, P; Marteau, P; Flourié, B; Bornet, F; Rambaud, J C

Bouhnik, Y; Vahedi, K; Achour, L; Attar, A; Salfati, J; Pochart, P; Marteau, P; Flourié, B; Bornet, F; Rambaud, J C.

Affiliation

Bouhnik Y; INSERM U 290, Fonctions intestinales, métabolisme et nutrition, Hôpital Saint-Lazare, 75010 Paris, France.

J Nutr ; 129(1): 113-6, 1999 Jan.

Article in En | MEDLINE | ID: mdl-9915885

ABSTRACT

Short-chain fructo-oligosaccharides (SC-FOS) are a mixture of oligosaccharides consisting of glucose linked to fructose units (Gfn; n =

Subject(s)

Bifidobacterium/growth & development; Feces/microbiology; Fructose/pharmacology; Oligosaccharides/pharmacology; Adolescent; Adult; Bifidobacterium/drug effects; Colony Count, Microbial; Dose-Response Relationship, Drug; Feces/chemistry; Female; Fructose/adverse effects; Fructose/chemistry; Gastrointestinal Diseases/chemically induced; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Oligosaccharides/adverse effects; Oligosaccharides/chemistry; Reference Values

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligosaccharides / Bifidobacterium / Feces / Fructose Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Nutr Year: 1999 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links